NEW YORK (GenomeWeb News) – KineMed and CHDI Foundation announced late on Monday a partnership to use KineMed's technology to investigate the turnover rates of huntingtin protein, which plays a crucial role in the pathogenesis of Huntington's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.